Tomasz Cierpicki

7.7k total citations
113 papers, 4.7k citations indexed

About

Tomasz Cierpicki is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Tomasz Cierpicki has authored 113 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 19 papers in Organic Chemistry and 17 papers in Hematology. Recurrent topics in Tomasz Cierpicki's work include Protein Degradation and Inhibitors (31 papers), Ubiquitin and proteasome pathways (18 papers) and Acute Myeloid Leukemia Research (17 papers). Tomasz Cierpicki is often cited by papers focused on Protein Degradation and Inhibitors (31 papers), Ubiquitin and proteasome pathways (18 papers) and Acute Myeloid Leukemia Research (17 papers). Tomasz Cierpicki collaborates with scholars based in United States, Poland and United Kingdom. Tomasz Cierpicki's co-authors include Jolanta Grembecka, Jacek Otlewski, John H. Bushweller, Trupta Purohit, Marcelo J. Murai, Daniel Krowarsch, Paweł Kafarski, Shihan He, Artur Mucha and Filip Jeleń and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Tomasz Cierpicki

110 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Cierpicki United States 40 3.5k 622 589 567 399 113 4.7k
Milton T. Stubbs Germany 41 3.4k 1.0× 964 1.5× 598 1.0× 607 1.1× 363 0.9× 117 5.6k
Lei Jin United States 33 2.7k 0.8× 528 0.8× 282 0.5× 355 0.6× 249 0.6× 53 4.2k
Glen Spraggon United States 37 2.3k 0.7× 339 0.5× 390 0.7× 454 0.8× 201 0.5× 70 4.0k
John H. Bushweller United States 44 4.9k 1.4× 1.2k 1.9× 195 0.3× 545 1.0× 410 1.0× 113 6.1k
E. Schönbrunn United States 42 3.8k 1.1× 420 0.7× 601 1.0× 736 1.3× 103 0.3× 96 5.4k
Fritz K. Winkler Switzerland 35 3.2k 0.9× 523 0.8× 289 0.5× 402 0.7× 192 0.5× 60 4.9k
Keith P. Wilson United States 26 3.2k 0.9× 212 0.3× 449 0.8× 495 0.9× 516 1.3× 35 4.4k
W.S. Somers United States 28 2.4k 0.7× 317 0.5× 361 0.6× 630 1.1× 974 2.4× 37 4.3k
Marjeta Urh United States 24 3.0k 0.9× 208 0.3× 615 1.0× 529 0.9× 166 0.4× 51 3.8k
Erinna F. Lee Australia 37 4.4k 1.2× 304 0.5× 406 0.7× 1.1k 1.9× 948 2.4× 73 5.5k

Countries citing papers authored by Tomasz Cierpicki

Since Specialization
Citations

This map shows the geographic impact of Tomasz Cierpicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Cierpicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Cierpicki more than expected).

Fields of papers citing papers by Tomasz Cierpicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Cierpicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Cierpicki. The network helps show where Tomasz Cierpicki may publish in the future.

Co-authorship network of co-authors of Tomasz Cierpicki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Cierpicki. A scholar is included among the top collaborators of Tomasz Cierpicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Cierpicki. Tomasz Cierpicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linhares, Brian M., Eungi Kim, Sergey N. Zolov, et al.. (2025). Discovery and Development of a Small-Molecule Inhibitor Targeting the GAS41 YEATS Domain in Nonsmall Cell Lung Cancer. Journal of Medicinal Chemistry. 68(23). 25324–25351.
2.
Grembecka, Jolanta, et al.. (2024). Drug-resistant menin variants retain high binding affinity and interactions with MLL1. Journal of Biological Chemistry. 300(10). 107777–107777. 8 indexed citations
3.
Rivas, Mónica, et al.. (2024). A Lipopeptidomimetic of Transcriptional Activation Domains Selectively Disrupts the Coactivator Med25 Protein–Protein Interactions. Angewandte Chemie International Edition. 63(21). e202400781–e202400781. 1 indexed citations
4.
Sheriff, Sulaiman, Travis W. Sawyer, Sinju Sundaresan, et al.. (2023). Clinically Defined Mutations in MEN1 Alter Its Tumor-suppressive Function Through Increased Menin Turnover. Cancer Research Communications. 3(7). 1318–1334. 4 indexed citations
5.
Breen, Meghan E., et al.. (2023). Garcinolic Acid Distinguishes Between GACKIX Domains and Modulates Interaction Networks. ChemBioChem. 24(21). e202300439–e202300439. 2 indexed citations
6.
Huang, G., Tomasz Cierpicki, & Jolanta Grembecka. (2023). 2-Aminobenzothiazoles in anticancer drug design and discovery. Bioorganic Chemistry. 135. 106477–106477. 33 indexed citations
7.
Svoboda, Laurie K., Ramón Ocádiz-Ruiz, Zeribe C. Nwosu, et al.. (2021). EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma. Molecular Cancer Research. 19(7). 1182–1195. 10 indexed citations
8.
Linhares, Brian M., Eungi Kim, Hyo Je Cho, et al.. (2021). Development of potent dimeric inhibitors of GAS41 YEATS domain. Cell chemical biology. 28(12). 1716–1727.e6. 18 indexed citations
9.
Henley, Matthew J., Brian M. Linhares, Brittany S. Morgan, et al.. (2020). Unexpected specificity within dynamic transcriptional protein–protein complexes. Proceedings of the National Academy of Sciences. 117(44). 27346–27353. 26 indexed citations
10.
Kempińska, Katarzyna, Bhavna Malik, Dmitry Borkin, et al.. (2017). Pharmacologic Inhibition of the Menin–MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 17(1). 26–38. 36 indexed citations
11.
Carpenter, Colleen, Roderick J. Sorenson, Szymon Kłossowski, et al.. (2016). Design and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C. Bioorganic & Medicinal Chemistry. 24(21). 5495–5504. 12 indexed citations
12.
Pinnell, Nancy, Ran Yan, Hyo Je Cho, et al.. (2015). The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia. Immunity. 43(5). 870–883. 48 indexed citations
13.
Abulwerdi, Fardokht A., Chenzhong Liao, Meilan Liu, et al.. (2013). A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(3). 565–575. 158 indexed citations
14.
Roberts, Morgan E., Brad H. Nelson, Jolanta Grembecka, et al.. (2013). Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and Hox Gene Expression in Hematopoietic Cells. Cancer Research. 73(19). 5892–5904. 42 indexed citations
15.
Dawson, Eric S., Noel Southall, Ajit Jadhav, et al.. (2013). Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction. Journal of Pineal Research. 57(1). 103–9. 2 indexed citations
16.
Shi, Aibin, Marcelo J. Murai, Shihan He, et al.. (2012). Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia. Blood. 120(23). 4461–4469. 152 indexed citations
17.
Caruso, Sarah, Morgan Jones, Rork Kuick, et al.. (2012). Convergence of the ZMIZ1 and NOTCH1 Pathways at C-MYC in Acute T Lymphoblastic Leukemias. Cancer Research. 73(2). 930–941. 45 indexed citations
18.
Xu, Hao, Paul D. Kirchhoff, Tomasz Cierpicki, et al.. (2012). Structure-Based Design of Novel Benzoxazinorifamycins with Potent Binding Affinity to Wild-Type and Rifampin-Resistant Mutant Mycobacterium tuberculosis RNA Polymerases. Journal of Medicinal Chemistry. 55(8). 3814–3826. 24 indexed citations
19.
Zhou, Yunpeng, Tomasz Cierpicki, Ricardo H. Flores Jiménez, et al.. (2008). NMR Solution Structure of the Integral Membrane Enzyme DsbB: Functional Insights into DsbB-Catalyzed Disulfide Bond Formation. Molecular Cell. 31(6). 896–908. 145 indexed citations
20.
Kim, Myung Hee, Tomasz Cierpicki, Urszula Derewenda, et al.. (2003). The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nature Structural & Molecular Biology. 10(5). 324–333. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milton T. Stubbs Breakdown of academic impact, for papers by Lei Jin Breakdown of academic impact, for papers by Glen Spraggon Breakdown of academic impact, for papers by John H. Bushweller Breakdown of academic impact, for papers by E. Schönbrunn Breakdown of academic impact, for papers by Fritz K. Winkler Breakdown of academic impact, for papers by Keith P. Wilson Breakdown of academic impact, for papers by W.S. Somers Breakdown of academic impact, for papers by Marjeta Urh Breakdown of academic impact, for papers by Erinna F. Lee
Rankless by CCL
2026